RadNet's subsidiary DeepHealth has concluded the previously announced acquisition of iCAD in a deal valued at $103m.

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

Charlie Whelan, a Senior Director of Consulting at GlobalData, discusses the latest trends in medical devices for 2025.

Xeltis has reported positive preliminary data for its Xabg coronary artery bypass conduit (CABG) in a trial that is underway at EU sites.

Bio-Techne has announced a collaboration to distribute Spear Bio’s advanced SPEAR UltraDetect immunoassays globally.

UroMems is set to enter the pivotal trial phase with its device for treating stress urinary incontinence (SUI).

Saluda Medical has announced the full US commercial launch of its EVA sensing technology intended for scanning and analysing the spinal cord.

Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours.

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

Medtronic has announced the first subject enrolment in the PELE trial, aiming to assess the Onyx liquid embolic system (LES).

Viome, with Scripps Research, is set to develop and clinically validate the first RNA test for detecting precancerous colon polyps.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software.